Atlas Trials

A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors

Clinical trial NCT04214093 · TERMINATED

Trial details

NCT number
NCT04214093
Sponsor
AstraZeneca
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid TumorsLymphomaMultiple MyelomaHematologic Malignancies
Start date
2019-12-16
Primary completion
2021-06-18
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.